SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is seeing intense community speculation as investors anticipate a major short squeeze, fueled by high short interest and heightened expectations ahead of upcoming earnings. Traders are actively debating the company's growth prospects, particularly regarding government contracts and drone technology, while monitoring price action closely for a breakout above key technical levels.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending as traders analyze its recent earnings report, which highlighted significant revenue growth and a record backlog despite a bottom-line miss. Community sentiment is deeply divided, with bulls pointing to the company's long-term potential as a space infrastructure leader while bears emphasize concerns over profitability, dilution, and the stock's recent volatility.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending following the official delivery and acceptance of its first AI cloud deployment to Microsoft, which validates the company's ability to execute on its massive long-term cloud services contract. Community discussions are heavily focused on the stock's potential for a short squeeze as investors weigh this de-risking milestone against active short positions and institutional interest from firms like Goldman Sachs.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is trending as investors weigh record revenue growth and a raised annual outlook against widening operating losses following the latest quarterly report. The community is actively debating the company's long-term potential in the quantum sector, contrasting its organic growth and government-backed contracts against intense institutional manipulation and market volatility.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco Systems is seeing strong market interest driven by high demand for AI-focused networking infrastructure and a robust order backlog. Investors and analysts are actively discussing the company's fiscal outlook and the role of its networking hardware as a critical backbone for enterprise AI expansion.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is seeing increased attention following a strong quarterly earnings report that featured significant revenue growth and raised adjusted EBITDA guidance. Community sentiment is currently driven by the announcement of a new commercial agreement with a major dialysis operator, coupled with anticipation surrounding the upcoming regulatory filing for REZZAYO prophylaxis.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending following the announcement of a massive, long-term lease agreement with TensorWave that provides commercial validation for its Project Matador facility. Investors are actively discussing the stock's future potential and the strategic importance of this first major customer, though community sentiment remains split between excitement over institutional growth and skepticism regarding the company's path to profitability.

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Abeona Therapeutics is currently in the spotlight as investors await Q2 earnings, closely tracking the company's ability to scale ZEVASKYN patient treatments and activate more qualified treatment centers. The community is actively debating the company's execution speed, with long-term holders emphasizing the potential for profitability as production capacity reaches a steady state.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is trending as investors digest its massive role in the AI infrastructure buildout, with the community actively comparing its valuation and server rack production capacity against peers like SuperMicro. Strong institutional interest remains high, though discussions are polarized between those betting on its long-term enterprise AI dominance and those concerned about its valuation relative to its diverse legacy hardware business.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing heightened community discussion following news that their strategic partner, Lumilens, has emerged from stealth with a multi-billion-dollar valuation and confirmed shipments to a major hyperscaler. Investors are actively debating the potential for this partnership to validate POET's production ramp, while speculating on the company's role within the broader AI infrastructure buildout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NVAX Q2 Earnings & Sales Beat Estimates, '26 Sales Outlook Raised

Novavax beat Q2 earnings and revenue estimates, raises its 2026 adjusted revenue outlook, cuts expense guidance and outlines potential Sanofi milestones ahead.

NVAX Stock Holds Steady As Novavax Lifts Revenue Outlook On Licensing Pivot — Retail Eyes Buyout, More Partnership Deals  

Equity

Novavax raised its full-year 2026 adjusted total revenue outlook to $235–$275 million from $230–$270 million.


ADMA Q2 Earnings Meet, Revenues Miss on Bivigam Weakness

ADMA Biologics matches earnings estimates, misses on revenues and maintains its 2026 outlook as strong Asceniv growth offsets continued pressure on Bivigam.

Novavax (NVAX) Reports Q2 Loss, Tops Revenue Estimates

Novavax (NVAX) delivered earnings and revenue surprises of +11.11% and +13.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Are Medical Stocks Lagging  Novavax (NVAX) This Year?

Here is how Novavax (NVAX) and Addus HomeCare (ADUS) have performed compared to their sector so far this year.

Novavax Slips To Loss In Q2 On Reduced Revenue, Cuts FY26 Guidance

(RTTNews) - On Thursday, Novavax, Inc. (NVAX), a biotechnology company, reported a slip to loss in the second quarter, due to lower total revenue generated, compared to the prior year. Further, the company lowered its guidance for fiscal 2026...

Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights

Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights PR Newswire GAITHERSBURG, Md., Aug. 6, 2026 Reported total revenue of $57 million for the second quarter of 2026 and raised full-year...

HRMY Q2 Earnings Beat Estimates on Strong Wakix Sales, Stock Up 

HRMY tops Q2 estimates as Wakix demand fuels 30% revenue growth. A growing pipeline, BP-205 progress and reaffirmed 2026 guidance add momentum.

NVAX Stock Rises Ahead Of Q2 Earnings As Focus Shifts To Licensing Deals

Novavax is scheduled to release its second-quarter 2026 financial results before the U.S. market opens on Thursday.


Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026

Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026 Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026 PR Newswire GAITHERSBURG, Md., July 30, 2026 GAITHERSBURG, Md., July 30, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that the...

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

NVAXNovavax Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest NVAX News